These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 7890768

  • 1. Inhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanism.
    Xu J, McKeehan K, Matsuzaki K, McKeehan WL.
    J Biol Chem; 1995 Mar 17; 270(11):6308-13. PubMed ID: 7890768
    [Abstract] [Full Text] [Related]

  • 2. Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin.
    Cárcamo J, Weis FM, Ventura F, Wieser R, Wrana JL, Attisano L, Massagué J.
    Mol Cell Biol; 1994 Jun 17; 14(6):3810-21. PubMed ID: 8196624
    [Abstract] [Full Text] [Related]

  • 3. Activin and inhibin binding to the soluble extracellular domain of activin receptor II.
    Donaldson CJ, Vaughan JM, Corrigan AZ, Fischer WH, Vale WW.
    Endocrinology; 1999 Apr 17; 140(4):1760-6. PubMed ID: 10098513
    [Abstract] [Full Text] [Related]

  • 4. A widely expressed transmembrane serine/threonine kinase that does not bind activin, inhibin, transforming growth factor beta, or bone morphogenic factor.
    Matsuzaki K, Xu J, Wang F, McKeehan WL, Krummen L, Kan M.
    J Biol Chem; 1993 Jun 15; 268(17):12719-23. PubMed ID: 8389764
    [Abstract] [Full Text] [Related]

  • 5. Identification of a binding site on the type II activin receptor for activin and inhibin.
    Gray PC, Greenwald J, Blount AL, Kunitake KS, Donaldson CJ, Choe S, Vale W.
    J Biol Chem; 2000 Feb 04; 275(5):3206-12. PubMed ID: 10652306
    [Abstract] [Full Text] [Related]

  • 6. Concomitant over-expression of activin/inhibin beta subunits and their receptors in human pancreatic cancer.
    Kleeff J, Ishiwata T, Friess H, Büchler MW, Korc M.
    Int J Cancer; 1998 Sep 11; 77(6):860-8. PubMed ID: 9714055
    [Abstract] [Full Text] [Related]

  • 7. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling.
    Lewis KA, Gray PC, Blount AL, MacConell LA, Wiater E, Bilezikjian LM, Vale W.
    Nature; 2000 Mar 23; 404(6776):411-4. PubMed ID: 10746731
    [Abstract] [Full Text] [Related]

  • 8. Formation and activation by phosphorylation of activin receptor complexes.
    Willis SA, Zimmerman CM, Li LI, Mathews LS.
    Mol Endocrinol; 1996 Apr 23; 10(4):367-79. PubMed ID: 8721982
    [Abstract] [Full Text] [Related]

  • 9. Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation.
    Lebrun JJ, Vale WW.
    Mol Cell Biol; 1997 Mar 23; 17(3):1682-91. PubMed ID: 9032295
    [Abstract] [Full Text] [Related]

  • 10. Differential expression of activin/inhibin subunit and activin receptor mRNAs in normal and neoplastic ovarian surface epithelium (OSE).
    Choi KC, Kang SK, Nathwani PS, Cheng KW, Auersperg N, Leung PC.
    Mol Cell Endocrinol; 2001 Mar 28; 174(1-2):99-110. PubMed ID: 11306176
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of vascular endothelial cell growth by activin-A.
    McCarthy SA, Bicknell R.
    J Biol Chem; 1993 Nov 05; 268(31):23066-71. PubMed ID: 8226823
    [Abstract] [Full Text] [Related]

  • 12. Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation.
    Di Simone N, Crowley WF, Wang QF, Sluss PM, Schneyer AL.
    Endocrinology; 1996 Feb 05; 137(2):486-94. PubMed ID: 8593793
    [Abstract] [Full Text] [Related]

  • 13. Two distinct signaling pathways activated by activin A in glucose-responsive pancreatic beta-cell lines.
    Shibata H, Kanzaki M, Takeuchi T, Miyazaki J, Kojima I.
    J Mol Endocrinol; 1996 Jun 05; 16(3):249-58. PubMed ID: 8782083
    [Abstract] [Full Text] [Related]

  • 14. Is the action of inhibin mediated via a unique receptor?
    Robertson DM, Hertan R, Farnworth PG.
    Rev Reprod; 2000 Sep 05; 5(3):131-5. PubMed ID: 11006162
    [Abstract] [Full Text] [Related]

  • 15. Regulation of inhibin/activin subunit messenger ribonucleic acids (mRNAs) by activin A and expression of activin receptor mRNAs in cultured human granulosa-luteal cells.
    Erämaa M, Hildén K, Tuuri T, Ritvos O.
    Endocrinology; 1995 Oct 05; 136(10):4382-9. PubMed ID: 7664658
    [Abstract] [Full Text] [Related]

  • 16. Determination of type I receptor specificity by the type II receptors for TGF-beta or activin.
    Ebner R, Chen RH, Lawler S, Zioncheck T, Derynck R.
    Science; 1993 Nov 05; 262(5135):900-2. PubMed ID: 8235612
    [Abstract] [Full Text] [Related]

  • 17. Molecular characterization of a type I serine-threonine kinase receptor for TGF-beta and activin in the rat pituitary tumor cell line GH3.
    Takumi T, Moustakas A, Lin HY, Lodish HF.
    Exp Cell Res; 1995 Jan 05; 216(1):208-14. PubMed ID: 7813622
    [Abstract] [Full Text] [Related]

  • 18. Expression and localization of inhibin/activin subunits and activin receptors in MCF-7 cells, a human breast cancer cell line.
    Ying SY, Zhang Z.
    Breast Cancer Res Treat; 1996 Jan 05; 37(2):151-60. PubMed ID: 8750582
    [Abstract] [Full Text] [Related]

  • 19. Activin signaling through activin receptor type II causes the cachexia-like symptoms in inhibin-deficient mice.
    Coerver KA, Woodruff TK, Finegold MJ, Mather J, Bradley A, Matzuk MM.
    Mol Endocrinol; 1996 May 05; 10(5):534-43. PubMed ID: 8732684
    [Abstract] [Full Text] [Related]

  • 20. Activin A and activin receptors in the human thyroid: a link to the female predominance of goiter?
    Schulte KM, Jonas C, Krebs R, Röher HD.
    Horm Metab Res; 2000 Oct 05; 32(10):390-400. PubMed ID: 11069203
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.